Magnet is advancing molecular glue discovery with rational selection and design to harness the vast untapped potential of TrueGlues™ to address human disease.
🌟 Magnet Biomedicine is excited to be at #JPM2024! Our leadership team (Brian Safina, Bret Williams, and Diala Ezzeddine) will discuss #TrueGlue technology and partnership opportunities. #MagnetBiomedicine#HealthcareInnovation
https://t.co/80SU5ifmx3
We had a great time chatting with @RLCscienceboss and @endpts about our Series A and the vast potential of molecular glues to address cancer, cardiovascular disease, immune disorders, and beyond 🧲
Check out the full article: https://t.co/KVUScNyjSH
Thank you to our team and scientific founders for your commitment to advancing pioneering science with the potential to unlock new therapeutics.
#TrueGlues#MolecularGlues#Biotech
Our TrueGlue™ discovery platform uses next-gen technologies to identify TrueGlues that offer notable benefits and opportunities to bring new medicines to patients.
Learn more: https://t.co/IXVRDY4ARS
#MolecularGlues#Biotech#DrugDiscovery
Today, Magnet Bio emerges from stealth with $50M in Series A financing to advance #MolecularGlue discovery with rational selection and design.
Learn more: https://t.co/tA00Kq16bV
#Biotech